Skip to Content
Merck
  • Mechanisms of protein oligomerization: inhibitor of functional amyloids templates α-synuclein fibrillation.

Mechanisms of protein oligomerization: inhibitor of functional amyloids templates α-synuclein fibrillation.

Journal of the American Chemical Society (2012-01-21)
Istvan Horvath, Christoph F Weise, Emma K Andersson, Erik Chorell, Magnus Sellstedt, Christoffer Bengtsson, Anders Olofsson, Scott J Hultgren, Matthew Chapman, Magnus Wolf-Watz, Fredrik Almqvist, Pernilla Wittung-Stafshede
ABSTRACT

Small organic molecules that inhibit functional bacterial amyloid fibers, curli, are promising new antibiotics. Here we investigated the mechanism by which the ring-fused 2-pyridone FN075 inhibits fibrillation of the curli protein CsgA. Using a variety of biophysical techniques, we found that FN075 promotes CsgA to form off-pathway, non-amyloidogenic oligomeric species. In light of the generic properties of amyloids, we tested whether FN075 would also affect the fibrillation reaction of human α-synuclein, an amyloid-forming protein involved in Parkinson's disease. Surprisingly, FN075 stimulates α-synuclein amyloid fiber formation as measured by thioflavin T emission, electron microscopy (EM), and atomic force microscopy (AFM). NMR data on (15)N-labeled α-synuclein show that upon FN075 addition, α-synuclein oligomers with 7 nm radius form in which the C-terminal 40 residues remain disordered and solvent exposed. The polypeptides in these oligomers contain β-like secondary structure, and the oligomers are detectable by AFM, EM, and size-exclusion chromatography (SEC). Taken together, FN075 triggers oligomer formation of both proteins: in the case of CsgA, the oligomers do not proceed to fibers, whereas for α-synuclein, the oligomers are poised to rapidly form fibers. We conclude that there is a fine balance between small-molecule inhibition and templation that depends on protein chemistry.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
2-Hydroxypyridine, 97%
Levetiracetam impurity C, European Pharmacopoeia (EP) Reference Standard